earnings
NASDAQ · URGN
UroGen Pharma Ltd.
Healthcare · Biotechnology
$34.40
Down-$5.79 (-16.82%)
Updated Nov 4, 2026, 7:48 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.05B
- P/E ratio
- -6.89
- Dividend yield
- 0.00%
- 52-week range
- $16.50 – $50.81
- Volume
- 1.24M
- Avg. volume
- 1.14M
Price performance · URGN
URGN price history
1M range · 0 trading sessions · Daily adjusted prices
URGN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest URGN news
The latest Smart Investors Daily articles mentioning URGN.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…